Skip to main content


Weitere Artikel dieser Ausgabe durch Wischen aufrufen

24.11.2021 | short review Open Access

Clinical challenges in the management of endocrine side effects of immuno-oncological therapies

memo - Magazine of European Medical Oncology
Peter Wolf, Thomas Scherer
Wichtige Hinweise

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.


Given the growing use of immune checkpoint inhibitor (ICI) therapy in oncology, the prevalence of endocrine side effects is rapidly increasing. As clinicians are nowadays frequently confronted with these side effects in routine clinical care, awareness, better knowledge of endocrine irAEs and their clinical presentation and diagnosis is crucial for an adequate management. In this short-review we give a compact overview of the recent recommendations for the management of endocrine irAE related to ICIs and highlight difficulties and uncertainties in current clinical practice.

Unsere Produktempfehlungen

Abo für kostenpflichtige Inhalte

Über diesen Artikel